
Pimicotinib, a once-daily oral CSF-1R inhibitor, is now FDA approved for adults with TGCT for whom surgery may worsen function or cause severe morbidity.
The New York Times reports that with the deficit over $1 trillion, President Barack Obama and GOP presidential pick Mitt Romney propose different prescriptions, especially regarding government health programs. Meanwhile, the Wall Street Journal reports on how health firms are preparing for possible election outcomes.
Read the full story:
For the New York Times story
Source: Kaiser Health News/The New York Times





